You make a compelling argument. The pitch was always SaaS which would lead to rapid uptake. I need to remind myself the exact timeframe but I'm sure the CEO thought revenue neutral was very close at IPO. I think it is miles away. Especially if they have to sell devices to each health service. And we still don't have the research studies done that support its use. Most new medical tech that claims to be better than the established options would take 5-10 years to get a decent foothold. If they work.
Covid - 4DX, page-31
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.5¢ |
Change
-0.005(0.94%) |
Mkt cap ! $215.4M | |||
| Open | High | Low | Value | Volume |
| 52.5¢ | 53.0¢ | 51.5¢ | $146.0K | 279.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 21156 | 52.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.0¢ | 310 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |